Theralase Technologies Inc (TLTFF)

[123414]

#CathieWood
#ARKK Invest Holdings
$TLTFF-PH2DATA BTD INPROGRESS



Cathie Wood would you care to look at the data for Theralase Phase 2 study?

Theralase Releases 3Q21 Financial Statements and Newsletter
Toronto, Ontario – November 29, 2021, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated compounds and their associated drug formulations with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses has released the Company’s unaudited 3Q2021 condensed interim consolidated Financial Statements (“Financial Statements”), which provides financial information on the previous fiscal quarter and the quarterly Newsletter (“Newsletter”) which provides an interim clinical data analysis on the Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC“) clinical study (“Study II”).

The Financial Statements can be found on the Company’s Website at www.theralase.com/financial-filings/

The Newsletter can be found on the Company’s website at tHERALASE QUARTER NEWSLETTER

Not a dollar yet but a great read Ma'am